全文获取类型
收费全文 | 74665篇 |
免费 | 44255篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 1530篇 |
儿科学 | 4284篇 |
妇产科学 | 619篇 |
基础医学 | 15553篇 |
口腔科学 | 5126篇 |
临床医学 | 12391篇 |
内科学 | 23049篇 |
皮肤病学 | 7509篇 |
神经病学 | 13175篇 |
特种医学 | 2297篇 |
外国民族医学 | 5篇 |
外科学 | 13884篇 |
综合类 | 82篇 |
一般理论 | 22篇 |
预防医学 | 4235篇 |
眼科学 | 1279篇 |
药学 | 5768篇 |
中国医学 | 1037篇 |
肿瘤学 | 7096篇 |
出版年
2023年 | 74篇 |
2022年 | 183篇 |
2021年 | 1462篇 |
2020年 | 5139篇 |
2019年 | 10907篇 |
2018年 | 10237篇 |
2017年 | 11531篇 |
2016年 | 12171篇 |
2015年 | 11984篇 |
2014年 | 11873篇 |
2013年 | 12410篇 |
2012年 | 4161篇 |
2011年 | 4062篇 |
2010年 | 8936篇 |
2009年 | 5271篇 |
2008年 | 1998篇 |
2007年 | 834篇 |
2006年 | 885篇 |
2005年 | 664篇 |
2004年 | 654篇 |
2003年 | 645篇 |
2002年 | 746篇 |
2001年 | 770篇 |
2000年 | 694篇 |
1999年 | 266篇 |
1998年 | 25篇 |
1997年 | 23篇 |
1996年 | 25篇 |
1995年 | 19篇 |
1994年 | 18篇 |
1993年 | 12篇 |
1992年 | 22篇 |
1991年 | 33篇 |
1990年 | 28篇 |
1989年 | 18篇 |
1988年 | 20篇 |
1987年 | 16篇 |
1986年 | 12篇 |
1985年 | 9篇 |
1984年 | 10篇 |
1983年 | 7篇 |
1982年 | 6篇 |
1981年 | 8篇 |
1980年 | 8篇 |
1979年 | 9篇 |
1974年 | 5篇 |
1973年 | 5篇 |
1971年 | 5篇 |
1967年 | 4篇 |
1966年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Luis Veloza Cristina Teixido Natalia Castrejon Fina Climent Ana Carri Marta Marginet Davide Soldini Blanca Gonzlez‐Farr Inmaculada Ribera‐Cortada Armando Lopez‐Guillermo Eva Gonzlez‐Barca Adriana Sierra Mileyka Herrera Cndida Gmez Adriana Garcia Olga Balagu Elias Campo Antonio Martinez 《Histopathology》2019,75(6):799-812
72.
Leyi Wang Saraswathi Lanka Debbie Cassout Nohra E. Mateus‐Pinilla Ganwu Li William C. Wilson Dongwan Yoo Paul Shelton Richard L. Fredrickson 《Transboundary and Emerging Diseases》2019,66(5):1809-1820
First described in 1955 in New Jersey, epizootic haemorrhagic disease (EHD) causes a severe clinical disease in wild and domestic ruminants worldwide. Epizootic haemorrhagic disease outbreaks occur in deer populations each year from summer to late autumn. The etiological agent is EHD virus (EHDV) which is a double‐stranded segmented icosahedral RNA virus. EHD virus utilizes point mutations and reassortment strategies to maintain viral fitness during infection. In 2018, EHDV serotype 2 was predominantly detected in deer in Illinois. Whole genome sequencing was conducted for two 2018 EHDV2 isolates (IL41747 and IL42218) and the sequence analyses indicated that IL42218 was a reassortant between different serotypes whereas IL41747 was a genetically stable strain. Our data suggest that multiple strains contribute to outbreaks each year. 相似文献
73.
74.
75.
76.
77.
78.
Tuberculosis (TB) remains one of a major health problem worldwide. Tuberculosis vaccine research has made an extraordinary progress over the past few years. However, there is still no replacement for the Bacillus Calmette‐Guérin vaccine, the only TB vaccine licensed for human use. Therefore, the discovery and development of new TB vaccines remains a priority. This article discusses current strategies used to diversify TB vaccines and includes discussion of the status of efforts to improve protection against Mycobacterium tuberculosis (M tb) infection or TB disease by developing new and safe TB vaccines. This article also highlights the current research efforts in immune‐enhancing approaches to improve vaccination efficacy. The development of more effective TB vaccines might have significant impact on global TB control. 相似文献
79.
Erika Cecon Anna Ivanova Marine Luka Florence Gbahou Anne Friederich Jean‐Luc Guillaume Patrick Keller Klaus Knoch Raise Ahmad Philippe Delagrange Michele Solimena Ralf Jockers 《Journal of pineal research》2019,66(2)
Melatonin receptors play important roles in the regulation of circadian and seasonal rhythms, sleep, retinal functions, the immune system, depression, and type 2 diabetes development. Melatonin receptors are approved drug targets for insomnia, non‐24‐hour sleep‐wake disorders, and major depressive disorders. In mammals, two melatonin receptors (MTRs) exist, MT1 and MT2, belonging to the G protein‐coupled receptor (GPCR) superfamily. Similar to most other GPCRs, reliable antibodies recognizing melatonin receptors proved to be difficult to obtain. Here, we describe the development of the first monoclonal antibodies (mABs) for mouse MT1 and MT2. Purified antibodies were extensively characterized for specific reactivity with mouse, rat, and human MT1 and MT2 by Western blot, immunoprecipitation, immunofluorescence, and proximity ligation assay. Several mABs were specific for either mouse MT1 or MT2. None of the mABs cross‐reacted with rat MTRs, and some were able to react with human MTRs. The specificity of the selected mABs was validated by immunofluorescence microscopy in three established locations (retina, suprachiasmatic nuclei, pituitary gland) for MTR expression in mice using MTR‐KO mice as control. MT2 expression was not detected in mouse insulinoma MIN6 cells or pancreatic beta‐cells. Collectively, we report the first monoclonal antibodies recognizing recombinant and native mouse melatonin receptors that will be valuable tools for future studies. 相似文献
80.